These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 24418809)

  • 1. Entry of hepatitis B and C viruses - recent progress and future impact.
    Baumert TF; Meredith L; Ni Y; Felmlee DJ; McKeating JA; Urban S
    Curr Opin Virol; 2014 Feb; 4():58-65. PubMed ID: 24418809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular virology of chronic hepatitis B and C: parallels, contrasts and impact on drug development and treatment outcome.
    Delaney WE
    Antiviral Res; 2013 Jul; 99(1):34-48. PubMed ID: 23602852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Similarities and differences in hepatitis B and C virus induced hepatocarcinogenesis.
    Szabó E; Páska C; Kaposi Novák P; Schaff Z; Kiss A
    Pathol Oncol Res; 2004; 10(1):5-11. PubMed ID: 15029254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B virus: virology, molecular biology, life cycle and intrahepatic spread.
    Karayiannis P
    Hepatol Int; 2017 Nov; 11(6):500-508. PubMed ID: 29098564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis viruses: live and let die.
    Herzer K; Sprinzl MF; Galle PR
    Liver Int; 2007 Apr; 27(3):293-301. PubMed ID: 17355449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental models of hepatitis B and C - new insights and progress.
    Thomas E; Liang TJ
    Nat Rev Gastroenterol Hepatol; 2016 Jun; 13(6):362-74. PubMed ID: 27075261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus entry into hepatocytes: molecular mechanisms and targets for antiviral therapies.
    Zeisel MB; Fofana I; Fafi-Kremer S; Baumert TF
    J Hepatol; 2011 Mar; 54(3):566-76. PubMed ID: 21146244
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specialization of Hepatitis C Virus Envelope Glycoproteins for B Lymphocytes in Chronically Infected Patients.
    Douam F; Bobay LM; Maurin G; Fresquet J; Calland N; Maisse C; Durand T; Cosset FL; Féray C; Lavillette D
    J Virol; 2016 Jan; 90(2):992-1008. PubMed ID: 26537674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogenic viruses and hepatocellular carcinoma.
    Ben Ari Z; Weitzman E; Safran M
    Clin Liver Dis; 2015 May; 19(2):341-60. PubMed ID: 25921667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C Virus Entry: An Intriguingly Complex and Highly Regulated Process.
    Colpitts CC; Tsai PL; Zeisel MB
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32197477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Novel Functions for Hepatitis C Virus Envelope Glycoprotein E1 in Virus Entry and Assembly.
    Haddad JG; Rouillé Y; Hanoulle X; Descamps V; Hamze M; Dabboussi F; Baumert TF; Duverlie G; Lavie M; Dubuisson J
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28179528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complete replication of hepatitis B virus and hepatitis C virus in a newly developed hepatoma cell line.
    Yang D; Zuo C; Wang X; Meng X; Xue B; Liu N; Yu R; Qin Y; Gao Y; Wang Q; Hu J; Wang L; Zhou Z; Liu B; Tan D; Guan Y; Zhu H
    Proc Natl Acad Sci U S A; 2014 Apr; 111(13):E1264-73. PubMed ID: 24616513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secreted Interferon-Inducible Factors Restrict Hepatitis B and C Virus Entry In Vitro.
    Xia Y; Cheng X; Blossey CK; Wisskirchen K; Esser K; Protzer U
    J Immunol Res; 2017; 2017():4828936. PubMed ID: 28367455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Visualization of hepatitis B virus entry - novel tools and approaches to directly follow virus entry into hepatocytes.
    Zhang Z; Zehnder B; Damrau C; Urban S
    FEBS Lett; 2016 Jul; 590(13):1915-26. PubMed ID: 27149321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic viral hepatitis and its association with liver cancer.
    Tu T; Bühler S; Bartenschlager R
    Biol Chem; 2017 Jul; 398(8):817-837. PubMed ID: 28455951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Hepatitis Viruses on the Nrf2/Keap1-Signaling Pathway and Its Impact on Viral Replication and Pathogenesis.
    Bender D; Hildt E
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31546975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic hepatitis B virus and hepatitis C virus infections and cancer: synergy between viral and host factors.
    Schinzari V; Barnaba V; Piconese S
    Clin Microbiol Infect; 2015 Nov; 21(11):969-74. PubMed ID: 26163104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virus entry and its inhibition to prevent and treat hepatitis B and hepatitis D virus infections.
    Tu T; Urban S
    Curr Opin Virol; 2018 Jun; 30():68-79. PubMed ID: 29775812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes.
    Ni Y; Lempp FA; Mehrle S; Nkongolo S; Kaufman C; Fälth M; Stindt J; Königer C; Nassal M; Kubitz R; Sültmann H; Urban S
    Gastroenterology; 2014 Apr; 146(4):1070-83. PubMed ID: 24361467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of hypervariable region 1 for the interplay of hepatitis C virus with entry factors and lipoproteins.
    Bankwitz D; Vieyres G; Hueging K; Bitzegeio J; Doepke M; Chhatwal P; Haid S; Catanese MT; Zeisel MB; Nicosia A; Baumert TF; Kaderali L; Pietschmann T
    J Virol; 2014 Nov; 88(21):12644-55. PubMed ID: 25142595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.